Cost-effectiveness of Human Papillomavirus Vaccination in the United States-Reference-Cited by-同舟云学术

Cost-effectiveness of Human Papillomavirus Vaccination in the United States

Published:2008-02 Issue:2 Volume:14 Page:244-251
ISSN:1080-6040
Container-title:Emerging Infectious Diseases
language:
Short-container-title:Emerg. Infect. Dis.

Author:

Chesson Harrell W.¹,Ekwueme Donatus U.¹,Saraiya Mona¹,Markowitz Lauri E.¹

Affiliation:

1. Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Publisher

Centers for Disease Control and Prevention (CDC)

Subject

Infectious Diseases,Microbiology (medical),Epidemiology

Reference40 articles.

1. Institute of Medicine. Vaccines for the 21st century: a tool for decisionmaking. Washington: National Academy of Sciences; 2000.

2. Chapter 2: the burden of HPV-related cancers.;Parkin;Vaccine,2006

3. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).;Centers for Disease Control and Prevention;MMWR Recomm Rep,2007

4. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis.;Clifford;Br J Cancer,2003

5. Genital human papillomavirus infection.;Dunne;Clin Infect Dis,2006

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human Papillomavirus Vaccine;Obstetrics and Gynecology Clinics of North America;2023-06

2. Vaccinating women previously treated for human papillomavirus-related cervical precancerous lesions is highly cost-effective in China;Frontiers in Immunology;2023-03-27

3. Human Papillomavirus Vaccines;Plotkin's Vaccines;2023

4. Increasing HPV vaccination coverage to prevent oropharyngeal cancer: A cost-effectiveness analysis;Tumour Virus Research;2022-06

5. Evaluating Risk-Stratified HPV Catch-up Vaccination Strategies: Should We Go beyond Age 26?;Medical Decision Making;2021-10-11